Published in JAMA on May 02, 1977
Cultural and physiological characteristics and antimicrobial susceptibility of Clostridium botulinum isolates from foodborne and infant botulism cases. J Clin Microbiol (1980) 2.94
Clostridium botulinum neurotoxin. Microbiol Rev (1980) 2.89
Laboratory diagnostics of botulism. Clin Microbiol Rev (2006) 2.32
Examination of feces and serum for diagnosis of infant botulism in 336 patients. J Clin Microbiol (1987) 1.56
Microbial ecological basis of infant botulism as studied with germfree mice. Infect Immun (1979) 1.44
Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores. Infect Immun (1978) 1.42
Serum antibody response to Clostridium botulinum toxin in infant botulism. J Clin Microbiol (1982) 1.16
The rat as an animal model for infant botulism. Infect Immun (1980) 1.06
Infant botulism in Canada. Can Med Assoc J (1981) 0.98
Clostridium botulinum in soil on the site of the former Metropolitan (Caledonian) Cattle Market, London. J Hyg (Lond) (1979) 0.97
Update: infant botulism. Clin Microbiol Rev (1996) 0.96
Isolation of Clostridium botulinum from Honey. J Clin Microbiol (1979) 0.89
Physician and parent response to the FDA advisory about use of over-the-counter cough and cold medications. Acad Pediatr (2009) 0.88
From poison to remedy: the chequered history of botulinum toxin. J Neural Transm (Vienna) (2007) 0.86
Infant botulism in the United States: an epidemiologic study of cases occurring outside of California. Am J Public Health (1983) 0.86
Use of ganglioside affinity filters to identify toxigenic strains of Clostridium botulinum types C and D. Infect Immun (1979) 0.81
Infant botulism. Can Med Assoc J (1978) 0.81
Botulinum toxin. From poison to medicine. West J Med (1993) 0.77
Evaluation of fluorescent-antibody tests as a means of confirming infant botulism. J Clin Microbiol (1984) 0.75
Neurology-epitomes of progress: syndrome of infant botulism. West J Med (1977) 0.75
Flaccid paralysis in an infant associated with a dirty wound and application of honey. BMJ Case Rep (2017) 0.75
Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol (1969) 4.93
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol (1989) 4.30
Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet (1976) 4.07
AIDS: an international perspective. Science (1988) 2.84
Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A (1989) 2.73
Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70
Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet (1978) 2.60
Prevention of chronic hepatitis B virus infection from mothers to infants in the United States. Pediatrics (1983) 2.41
Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis (1989) 2.38
Global surveillance and forecasting of AIDS. Bull World Health Organ (1989) 2.17
The international epidemiology of AIDS. Sci Am (1988) 2.08
Secondary neoplasms of the breast: a survey of the 20th Century. Cancer (2001) 2.07
Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster. Proc Natl Acad Sci U S A (1992) 2.06
High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) (2010) 2.02
Fluorescent treponemal-antibody absorption tests. Studies of false-positive reactions to tests for syphilis. N Engl J Med (1967) 1.91
Filter paper disc method of collecting whole blood for serologic studies in children. Am J Epidemiol (1966) 1.82
Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation. J Biol Chem (1994) 1.79
Infant botulism. Annu Rev Med (1980) 1.76
Honey and other environmental risk factors for infant botulism. J Pediatr (1979) 1.68
Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes. J Exp Med (1988) 1.66
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 1.66
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A (2001) 1.63
Country-specific estimates and models of HIV and AIDS: methods and limitations. AIDS (1999) 1.61
Immunocytochemical detection of interleukin 1 within stimulated human monocytes. J Exp Med (1986) 1.57
Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol (2000) 1.54
A Method for Obtaining Massive Growth of Bacteria in Fluid Media. Science (1948) 1.53
Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001. Intern Med J (2004) 1.53
Botulism--diagnosis, management and public health considerations. Calif Med (1973) 1.52
Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A (1988) 1.52
Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol (1999) 1.51
Public health implications of rubella antibody levels in California. Am J Public Health (1982) 1.51
The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med (1995) 1.47
Clinical trial of botulism immune globulin for infant botulism. West J Med (1991) 1.45
Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry (1999) 1.40
Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy. J Urol (2003) 1.40
Infant botulism: epidemiology and relation to sudden infant death syndrome. Epidemiol Rev (1981) 1.38
Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis (1980) 1.37
A Darkfield Colony Illuminator. Am J Public Health Nations Health (1947) 1.37
Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum. Appl Microbiol (1972) 1.37
The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study. Prostate (2006) 1.33
Quality control of individual components used in Middlebrook 7H10 medium for mycobacterial susceptibility testing. J Clin Microbiol (1988) 1.32
Use of immunofluorescence and animal tests to detect growth and toxin production by Clostridum botulinum type E in food. Appl Microbiol (1968) 1.32
Yeast glycolytic mRNAs are differentially regulated. Mol Cell Biol (1991) 1.32
Clostridium botulinum type F: isolation from venison jerky. Appl Microbiol (1972) 1.31
Review of AIDS and HIV infection: global epidemiology and statistics. AIDS (1989) 1.30
Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol (1984) 1.29
IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J Immunol (1994) 1.28
Use of immunofluorescence to identify Clostridium botulinum types A, B, and E. Public Health Rep (1967) 1.26
Antimicrobial resistance and R factors in Salmonella isolated in California (1971-1972). Antimicrob Agents Chemother (1974) 1.24
Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts. J Exp Med (1987) 1.21
Infant botulism: anticipating the second decade. J Infect Dis (1986) 1.21
Pyrroles and other heterocycles as inhibitors of p38 kinase. Bioorg Med Chem Lett (1998) 1.18
Controversy over use of pregnant mare's urine. CMAJ (1995) 1.17
Testing of hypoxic cell radiosensitizers in vivo. Br J Cancer Suppl (1978) 1.16
Diagnosis and management of infant botulism. Am J Dis Child (1979) 1.16
Modulating immune responses with probiotic bacteria. Immunol Cell Biol (2000) 1.15
Interleukin 1 beta (IL-1 beta) processing in murine macrophages requires a structurally conserved homologue of human IL-1 beta converting enzyme. Proc Natl Acad Sci U S A (1993) 1.14
Multiple Symmetrical Lipomatosis--a mitochondrial disorder of brown fat. Mitochondrion (2013) 1.13
Antibodies of predetermined specificity to the major charged species of human interleukin 1. Proc Natl Acad Sci U S A (1986) 1.13
Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1. J Exp Med (1986) 1.10
Evaluation of a selective medium for mycobacteria. Am J Clin Pathol (1973) 1.10
CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group. Urology (1999) 1.09
Cooperative field test of drug-impregnated discs for susceptibility testing of mycobacteria. Am Rev Respir Dis (1971) 1.08
A second case of infant botulism type F caused by Clostridium baratii. Pediatr Infect Dis J (1995) 1.08
Prevention of hepatitis B in infants born to HBsAg-carrier mothers. West J Med (1984) 1.07
Room temperature storage of Treponema pallidum on microscope slides for use in the FTA-ABS test. Appl Microbiol (1969) 1.06
Avoidance of rubella immunization of women during or shortly before pregnancy. JAMA (1971) 1.06
The clinical spectrum of infant botulism. Rev Infect Dis (1980) 1.05
Iron regulates the activity of the iron-responsive element binding protein without changing its rate of synthesis or degradation. J Biol Chem (1992) 1.05
An outbreak of hepatitis B associated with jet injections in a weight reduction clinic. Arch Intern Med (1990) 1.03
Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants. J Clin Microbiol (1985) 1.03
Raw milk: a continuing vehicle for the transmission of infectious disease agents in the United States. J Infect Dis (1982) 1.03
Grafting of the maxillary sinus with intraorally harvested autogenous bone prior to implant placement. Int J Oral Maxillofac Implants (1988) 1.02
Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc Natl Acad Sci U S A (1992) 1.01
The incidence of toxic shock syndrome in Northern California. 1972 through 1983. JAMA (1986) 1.01
A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol (1993) 1.00
Food and environmental aspects of infant botulism in California. Rev Infect Dis (1980) 1.00
Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis. J Pediatr (1984) 1.00
Cathepsins A, B, C, D and autolysis during development of breast muscle of normal and dystrophic chickens. Arch Biochem Biophys (1972) 1.00
Long-term regulation of neuronal high-affinity glutamate and glutamine uptake in Aplysia. Proc Natl Acad Sci U S A (2000) 0.99
Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency. Bone (1998) 0.98
Evaluation of an automated fluorescent treponemal antibody test for syphilis. Br J Vener Dis (1970) 0.98
An iron-sulfur cluster plays a novel regulatory role in the iron-responsive element binding protein. Biometals (1992) 0.98